Location: RM 271
OPIOID AND OTHER SUBSTANCE USE DISORDERS
|Votes: View-->||Action Taken:|
04:16 PM -- Public Comment
Representative Pettersen opened the meeting for public testimony.
04:17 PM -- Jessica LeRoux, representing herself, testified regarding the dangers of benzodiazepine withdrawal. Discussion with the committee ensued.
04:20 PM -- Cindy Sovine-Miller, representing herself, distributed two handouts to the committee (Attachments P and Q) and testified regarding the safety of medical marijuana compared to other pain medications. Ms. Sovine-Miller responded to questions from the committee.
Senator Aguilar commented on ideas for legislation, including limiting prescriptions for new patients, renewing the Attorney General's Task Force, integrating the PDMP into electronic health records, tracking additional drugs in the PDMP, removing pain as a patient 'vital sign', adjusting prescription formulations, and controlling the cost of generic prescriptions.
04:31 PM -- Dale Terasaki, representing himself, testified regarding the effectiveness of safe injection sites to prevent overdoses.
04:32 PM -- Denise Vincioni, representing the Denver Recovery Group, testified regarding the substance use disorder recovery workforce shortage.
Representative Pettersen reminded the committee that the next meeting is scheduled for August 1, 2017, and requested feedback on the draft agenda for the next meeting.
Representative Pettersen adjourned the meeting.